In metabolic dysfunction-associated steatotic liver disease (MASLD), elevated serum levels of GDF15 were positively correlated with the severity of hepatic inflammation and fibrosis [13,14]. This evidence concerns the gene GDF15 and metabolic dysfunction-associated steatotic liver disease.